株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

核酸増幅検査市場分析:用途別(感染症、癌、個別化医療、遺伝子)、技術別(標的増幅、プローブ増幅、信号増幅)、セグメント予測

Nucleic Acid Amplification Testing Market Analysis By Application (Infectious Diseases, Cancer, Personalized Medicine, Genetic), By Technique (target amplification, probe amplification, & signal amplification), And Segment Forecasts, 2014 - 2025

発行 Grand View Research, Inc. 商品コード 478637
出版日 ページ情報 英文 90 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.19円で換算しております。
Back to Top
核酸増幅検査市場分析:用途別(感染症、癌、個別化医療、遺伝子)、技術別(標的増幅、プローブ増幅、信号増幅)、セグメント予測 Nucleic Acid Amplification Testing Market Analysis By Application (Infectious Diseases, Cancer, Personalized Medicine, Genetic), By Technique (target amplification, probe amplification, & signal amplification), And Segment Forecasts, 2014 - 2025
出版日: 2017年02月10日 ページ情報: 英文 90 Pages
概要

当レポートでは、世界の核酸増幅検査市場について調査し、市場の動向、用途別、技術別、地域別動向、市場に参入する主要企業のプロファイルなどをまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場セグメンテーションと範囲
    • 市場促進因子分析
    • 市場阻害因子分析
  • 浸透と成長見通しマッピング
  • SWOT分析
  • 業界分析:ポーターズ

第4章 用途別予測と動向分析

  • 用途別動向分析および市場シェア
  • 感染症
  • 個別化医療
  • 遺伝子疾患およびミトコンドリア疾患

第5章 技術別予測と動向分析

  • 技術別動向分析
  • 標的増幅システム
  • プローブ増幅システム
  • 信号増幅システム

第6章 地域別予測と動向分析

  • 市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合環境

  • 戦略枠組み
  • 市場参入カテゴリー
  • 企業プロファイル
目次
Product Code: GVR-1-68038-388-1

The global nucleic acid amplification test (NAAT) market is expected to reach USD 4.4 Billion by 2025, according to a new report by Grand View Research, Inc. Nucleic acid amplification testing is gaining preference over traditional diagnostic techniques because of its high efficiency and accuracy. In addition, the potential application of these tests in various life-threatening diseases, including several types of cancer, is attracting a large amount of investment for the purpose of R&D. Increasing number of ongoing studies are expected to ensure higher growth rate in the later part of the forecast period.

These tests are currently being used extensively for screening and diagnosis of a wide range of infectious diseases. Along with known infectious diseases, management of epidemics of new diseases has caused a sudden surge in the demand for advanced diagnostic tests. NAAT is currently the most advanced and efficient diagnostic method, which extensively uses technology that helps in reducing procedural time and consumption of reagents.

Further Key Findings from the Study Suggest:

  • The market study suggests that infectious diseases segment captured the largest revenue share in 2015 owing to the high demand for effective screening methods for management of these diseases
  • Cancer is expected to exhibit the fastest growth during the forecast period due to the rising number of studies to develop tests for early detection of various cancer types
  • Expanding applications prenatal screening and for the detection of mitochondrial disorders is expected to boost the demand for NAAT
  • High usage of the PCR technique in NAT is driving the growth of the segment and is expected to capture significant revenue share in the near future
  • North America dominated the space in 2015 with U.S. capturing the largest share
  • Evolution of biotechnology sector in the Asia Pacific, along with the favorable government initiatives, Asia Pacific is expected to show the fastest growth rate during the forecast period
  • A few of the major players in the market are F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Becton, Dickinson and Company; Novartis AG; Beckman Coulter, Inc.; bioMerieux SA; Abbott Laboratories; Siemens Healthineers, and Illumina, Inc.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis
  • 1.3 Approaches for Market Estimation
    • 1.3.1 Approach 1: Demand Analysis& Bottom up Approach
    • 1.3.2 Approach 2: Top-down market estimation
    • 1.3.3 Approach 3: Commodity flow and bottom-up market estimation
    • 1.3.4 Approach 4: KoL perspective-based market sizing

Chapter 2 Executive Summary

  • 2.1 Market Segmentation& Scope

Chapter 3 Nucleic Acid Amplification Testing Market Variables, Trends & Scope

  • 3.1 Market Segmentation& Scope
    • 3.1.1 Market driver analysis
    • 3.1.2 Market restraint analysis
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Nucleic Acid Amplification Testing Systems-SWOT Analysis, by Factor (political & legal, economic and technological)
  • 3.4 Industry Analysis - Porter's

Chapter 4 Nucleic Acid Amplification Testing: Application Estimates & Trend Analysis

  • 4.1 Nucleic Acid Amplification Testing Market: Application Movement Analysis
  • 4.2 Infectious Disease
    • 4.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 4.2.2 Virus
      • 4.2.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 4.2.3 Bacteria
      • 4.2.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 4.2.4 Others
      • 4.2.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 4.3 Cancer
    • 4.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 4.4 Personalized Medicine
    • 4.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 4.5 Genetic and Mitochondrial Disorders
    • 4.5.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)

Chapter 5 Nucleic Acid Amplification Testing: Technique Estimates & Trend Analysis

  • 5.1 Nucleic Acid Amplification Testing Market: Technique Movement Analysis
  • 5.2 Target Amplification Systems
    • 5.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 5.3 Probe Amplification Systems
    • 5.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 5.4 Signal Amplification Systems
    • 5.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)

Chapter 6 Nucleic Acid Amplification Testing: Regional Estimates & Trend Analysis, by Application, and Techniques

  • 6.1 Nucleic Acid Amplification Testing: Region Movement Analysis
  • 6.2 North America
    • 6.2.1 Market Estimates and Forecast, 2014 - 2024 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe nucleic acid amplification testing market, 2014 - 2025 (USD Million)
    • 6.3.2 U.K.
      • 6.3.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.4.2 China
      • 6.4.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.4.3 India
      • 6.4.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
  • 6.6 Middle East and Africa (MEA)
    • 6.6.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Strategy Framework
  • 7.2 Market Participation Categorization
  • 7.3 Company Profiles
    • 7.3.1 Becton, Dickinson and Company
      • 7.3.1.1 Company overview
      • 7.3.1.2 Financial performance
      • 7.3.1.3 Product benchmarking
      • 7.3.1.4 Strategic initiatives
    • 7.3.2 Hoffmann-La Roche Ltd
      • 7.3.2.1 Company overview
      • 7.3.2.2 Financial performance
      • 7.3.2.3 Product benchmarking
      • 7.3.2.4 Strategic initiatives
    • 7.3.3 Siemens Healthcare GmbH
      • 7.3.3.1 Company overview
      • 7.3.3.2 Financial performance
      • 7.3.3.3 Product benchmarking
      • 7.3.3.4 Strategic initiatives
    • 7.3.4 Bio-Rad Laboratories, Inc.
      • 7.3.4.1 Company overview
      • 7.3.4.2 Financial performance
      • 7.3.4.3 Product benchmarking
      • 7.3.4.4 Strategic initiatives
    • 7.3.5 bioMerieux SA
      • 7.3.5.1 Company overview
      • 7.3.5.2 Financial performance
      • 7.3.5.3 Product benchmarking
      • 7.3.5.4 Strategic initiatives
    • 7.3.6 Illumina, Inc.
      • 7.3.6.1 Company overview
      • 7.3.6.2 Financial performance
      • 7.3.6.3 Product benchmarking
      • 7.3.6.4 Strategic initiatives
    • 7.3.7 Grifols SA
      • 7.3.7.1 Company overview
      • 7.3.7.2 Financial performance
      • 7.3.7.3 Product benchmarking
      • 7.3.7.4 Strategic initiatives
    • 7.3.8 Beckman Coulter, Inc.
      • 7.3.8.1 Company overview
      • 7.3.8.2 Financial performance
      • 7.3.8.3 Product benchmarking
      • 7.3.8.4 Strategic initiatives
    • 7.3.9 Abbott
      • 7.3.9.1 Company overview
      • 7.3.9.2 Financial performance
      • 7.3.9.3 Product benchmarking
      • 7.3.9.4 Strategic initiatives
    • 7.3.10 Hologic, Inc.
      • 7.3.10.1 Company overview
      • 7.3.10.2 Financial performance
      • 7.3.10.3 Product benchmarking
      • 7.3.10.4 Strategic initiatives

List of Tables

  • TABLE 1: North America nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 2: North America infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 3: North America nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 4: U.S. nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 5: U.S. infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 6: U.S. nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 7: Canada nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 8: Canada infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 9: Canada nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 10: Europe nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 11: Europe infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 12: Europe nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 13: U.K. nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 14: U.K. infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 15: U.K. nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 16: Germany nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 17: Germany infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 18: Germany nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 19: Asia Pacific nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 20: Asia Pacific infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 21: Asia Pacific nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 22: China nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 23: China infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 24: China nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 25: India nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 26: India infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 27: India nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 28: Latin America nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 29: Latin America infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 30: Latin America nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 31: Brazil nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 32: Brazil infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 33: Brazil nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 34: Mexico nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 35: Mexico infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 36: Mexico nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 37: MEA nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 38: MEA infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 39: MEA nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
  • TABLE 40: South Africa nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 41: South Africa infectious diseases market, by type 2014 - 2025 (USD Million)
  • TABLE 42: South Africa nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1: Market research process
  • FIG. 2: Information procurement
  • FIG. 3: Primary research pattern
  • FIG. 4: Market research approaches
  • FIG. 5: Value chain based sizing & forecasting
  • FIG. 6: QFD modeling for market share assessment
  • FIG. 7: Market summary (USD Million)
  • FIG. 8: Market trends & outlook
  • FIG. 9: Market segmentation & scope
  • FIG. 10: Market driver relevance analysis (Current & future impact)
  • FIG. 11: Market restraint relevance analysis (Current & future impact)
  • FIG. 12: Penetration & growth prospect mapping
  • FIG. 13: SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 14: Porter's Five Forces Analysis
  • FIG. 15: Nucleic acid amplification market: Application outlook key takeaways
  • FIG. 16: Nucleic acid amplification testing: Application movement analysis
  • FIG. 17: Infectious disease market, 2014 - 2025 (USD Million)
  • FIG. 18: Virus market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 19: Bacteria market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 20: Others market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 21: Cancer market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 22: Personalized medicine market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 23: Genetic and mitochondrial disorders market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 24: Nucleic acid amplification testing market technique outlook key takeaways
  • FIG. 25: Nucleic acid amplification testing: Technique movement analysis
  • FIG. 26: Target amplification systems market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 27: Probe amplification systems market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 28: Signal amplification systems market estimates and forecast, 2014 - 2025 (USD Million)
  • FIG. 29: Regional market place: Key takeaways
  • FIG. 30: Nucleic acid amplification testing: Region movement analysis
  • FIG. 31: Strategy framework
  • FIG. 32: Participant categorization
Back to Top